{
  "main_header": {
    "sid": 138636,
    "name": "Mangalam Drugs",
    "stock_name": "Mangalam Drugs",
    "full_name": "Mangalam Drugs and Organics Ltd",
    "name_url": "stocks-analysis/mangalam-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "30.25",
    "chg": -0.02,
    "chgp": "-0.07%",
    "dir": -1,
    "prev_price": "30.27",
    "mcapval": "47.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532637,
    "symbol": "MANGALAM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE584F01014",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "16.04 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/mangalam-drugs-138636-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Mangalam Drugs and Organics reports consolidated net loss of Rs 13.42 crore in the March 2026 quarter",
        "link": "https://news.google.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?oc=5",
        "imagepath": "",
        "date": "2026-05-15 12:02:12",
        "description": "Mangalam Drugs and Organics reports consolidated net loss of Rs 13.42 crore in the March 2026 quarter  Business Standard..."
      }
    ],
    "total": 1,
    "sid": "138636",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/mangalam-drugs-and-organics-138636"
  },
  "announcements": [
    {
      "caption": "Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure",
      "datetime": "17-Jun-2026",
      "details": "Subsequent Disclosure under Regulation 30 part A of Schedule III of SEBI (Listing Obligation and Discloure Requirements) Regulations 2015 of default of Bank Loan account.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "25-May-2026",
      "details": "Annual Secretarial Compliance Report to be filed for the financial year ended March 31 2026 as per Regulation 24A of SEBI LODR 2025.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "25-May-2026",
      "details": "Submission of Annual Secretarial Compliance Report for the period ended 31st March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mangalam Drugs and Organics Ltd has declared <strong>5%</strong> dividend, ex-date: 21 Dec 17",
          "dt": "2017-12-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Mangalam Drugs and Organics reports consolidated net loss of Rs 13.42 crore in the March 2026 quarter

2026-05-15 12:02:12

Mangalam Drugs and Organics reports consolidated net loss of Rs 13.42 crore in the March 2026 quarter Business Standard...

Read More

View All News